Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir Parekh

Showing results (21-30 of 162) with videos related to

Pageof 17
Sort By:
The New England Journal of Medicine|August 2, 2013
More on hepatocellular carcinoma after the Fontan procedureRobert W Elder, Samir Parekh, Wendy M Book
Advances in Hematology|May 10, 2012
Paradigms and Controversies in the Treatment of HIV-Related Burkitt LymphomaAdam M Petrich, Joseph A Sparano, Samir Parekh
Blood|November 7, 2007
Lenalidomide-induced severe hepatotoxicitySubuhee Hussain, Royston Browne, Julie Chen, et al.
American Journal of Hematology|April 26, 2005
Chronic parvovirus infection and G6PD deficiency masquerading as Diamond-Blackfan anemiaSamir Parekh, Alejandra Perez, Xiao Yan Yang, et al.
Photodermatology, Photoimmunology & Photomedicine|March 6, 2013
Is non-alcoholic steatohepatitis a predisposing factor to porphyria cutanea tarda?Elizabeth N Ergen, Elizabeth Seidler, Samir Parekh, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 14, 2024
Charting the Course: Sequencing Immunotherapy for Multiple MyelomaMeera Mohan, Oliver Van Oekelen, Othman Salim Akhtar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2013
Integrative genomic analysis of temozolomide resistance in diffuse large B-cell lymphomaVioletta V Leshchenko, Pei-Yu Kuo, Zewei Jiang, et al.
Personalized Medicine|March 29, 2016
Integrative network modeling approaches to personalized cancer medicineBrian A Kidd, Ben P Readhead, Caroline Eden, et al.
Genes & Cancer|September 2, 2022
CDK4: a master regulator of the cell cycle and its role in cancerStacey J Baker, Poulikos I Poulikakos, Hanna Y Irie, et al.
American Journal of Hematology|September 2, 2009
Atypical presentations of Sweet's syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitorsCristina Alencar, Matthew Abramowtiz, Samir Parekh, et al.
Pageof 17

Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
The New England Journal of Medicine|August 2, 2013
More on hepatocellular carcinoma after the Fontan procedureRobert W Elder, Samir Parekh, Wendy M Book
Advances in Hematology|May 10, 2012
Paradigms and Controversies in the Treatment of HIV-Related Burkitt LymphomaAdam M Petrich, Joseph A Sparano, Samir Parekh
Blood|November 7, 2007
Lenalidomide-induced severe hepatotoxicitySubuhee Hussain, Royston Browne, Julie Chen, et al.
American Journal of Hematology|April 26, 2005
Chronic parvovirus infection and G6PD deficiency masquerading as Diamond-Blackfan anemiaSamir Parekh, Alejandra Perez, Xiao Yan Yang, et al.
Photodermatology, Photoimmunology & Photomedicine|March 6, 2013
Is non-alcoholic steatohepatitis a predisposing factor to porphyria cutanea tarda?Elizabeth N Ergen, Elizabeth Seidler, Samir Parekh, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 14, 2024
Charting the Course: Sequencing Immunotherapy for Multiple MyelomaMeera Mohan, Oliver Van Oekelen, Othman Salim Akhtar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2013
Integrative genomic analysis of temozolomide resistance in diffuse large B-cell lymphomaVioletta V Leshchenko, Pei-Yu Kuo, Zewei Jiang, et al.
Personalized Medicine|March 29, 2016
Integrative network modeling approaches to personalized cancer medicineBrian A Kidd, Ben P Readhead, Caroline Eden, et al.
Genes & Cancer|September 2, 2022
CDK4: a master regulator of the cell cycle and its role in cancerStacey J Baker, Poulikos I Poulikakos, Hanna Y Irie, et al.
American Journal of Hematology|September 2, 2009
Atypical presentations of Sweet's syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitorsCristina Alencar, Matthew Abramowtiz, Samir Parekh, et al.
Pageof 17